Chronic lung allograft dysfunction following lung transplantation: challenges and solutions

Bradford C Bemiss, Chad A WittDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, MO, USAAbstract: Chronic rejection is a major cause of death after the first year following lung transplantation. Bronchiolitis oblite...

Full description

Bibliographic Details
Main Authors: Bemiss BC, Witt CA
Format: Article
Language:English
Published: Dove Medical Press 2014-09-01
Series:Transplant Research and Risk Management
Online Access:http://www.dovepress.com/chronic-lung-allograft-dysfunction-following-lung-transplantation-chal-peer-reviewed-article-TRRM
id doaj-f1e21769baeb48c7bc4df4270d225008
record_format Article
spelling doaj-f1e21769baeb48c7bc4df4270d2250082020-11-25T00:23:43ZengDove Medical PressTransplant Research and Risk Management1179-16162014-09-012014default879718516Chronic lung allograft dysfunction following lung transplantation: challenges and solutionsBemiss BCWitt CA Bradford C Bemiss, Chad A WittDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, MO, USAAbstract: Chronic rejection is a major cause of death after the first year following lung transplantation. Bronchiolitis obliterans (BO) is the most common pathologic finding on biopsy, characterized by fibrous granulation tissue, which obliterates the lumen of the bronchiole. Clinically, in the absence of tissue for pathology, BO syndrome refers to a progressive irreversible drop in the forced expiratory volume in 1 second. Recently, a broader definition of chronic rejection, termed "chronic lung allograft dysfunction", has been used to encompass a more inclusive definition of posttransplant dysfunction. Recently, the lung transplant community has come to realize that chronic rejection may be the final common result after repetitive epithelial insults. Acute rejection, infection, and alloreactivity to mismatched HLA antigens are a few of these insults that damage the surface of the bronchioles. Recent evidence of autoimmunity to the normally hidden structural proteins collagen V and K-α1 tubulin have been correlated with a BO phenotype as well, perhaps correlating the epithelial damage with a mechanism for developing BO lesions. Many immunomodulatory medications and treatments have been studied for effectiveness for the treatment of chronic lung allograft dysfunction. New drugs, which more precisely target the immune system, are being developed and tested. Further study is required, but recent advances have improved our understanding of the pathogenesis and potential intervention for this common and deadly complication of lung transplantation.Keywords: lung transplant, bronchiolitis obliterans syndrome, rejectionhttp://www.dovepress.com/chronic-lung-allograft-dysfunction-following-lung-transplantation-chal-peer-reviewed-article-TRRM
collection DOAJ
language English
format Article
sources DOAJ
author Bemiss BC
Witt CA
spellingShingle Bemiss BC
Witt CA
Chronic lung allograft dysfunction following lung transplantation: challenges and solutions
Transplant Research and Risk Management
author_facet Bemiss BC
Witt CA
author_sort Bemiss BC
title Chronic lung allograft dysfunction following lung transplantation: challenges and solutions
title_short Chronic lung allograft dysfunction following lung transplantation: challenges and solutions
title_full Chronic lung allograft dysfunction following lung transplantation: challenges and solutions
title_fullStr Chronic lung allograft dysfunction following lung transplantation: challenges and solutions
title_full_unstemmed Chronic lung allograft dysfunction following lung transplantation: challenges and solutions
title_sort chronic lung allograft dysfunction following lung transplantation: challenges and solutions
publisher Dove Medical Press
series Transplant Research and Risk Management
issn 1179-1616
publishDate 2014-09-01
description Bradford C Bemiss, Chad A WittDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, MO, USAAbstract: Chronic rejection is a major cause of death after the first year following lung transplantation. Bronchiolitis obliterans (BO) is the most common pathologic finding on biopsy, characterized by fibrous granulation tissue, which obliterates the lumen of the bronchiole. Clinically, in the absence of tissue for pathology, BO syndrome refers to a progressive irreversible drop in the forced expiratory volume in 1 second. Recently, a broader definition of chronic rejection, termed "chronic lung allograft dysfunction", has been used to encompass a more inclusive definition of posttransplant dysfunction. Recently, the lung transplant community has come to realize that chronic rejection may be the final common result after repetitive epithelial insults. Acute rejection, infection, and alloreactivity to mismatched HLA antigens are a few of these insults that damage the surface of the bronchioles. Recent evidence of autoimmunity to the normally hidden structural proteins collagen V and K-α1 tubulin have been correlated with a BO phenotype as well, perhaps correlating the epithelial damage with a mechanism for developing BO lesions. Many immunomodulatory medications and treatments have been studied for effectiveness for the treatment of chronic lung allograft dysfunction. New drugs, which more precisely target the immune system, are being developed and tested. Further study is required, but recent advances have improved our understanding of the pathogenesis and potential intervention for this common and deadly complication of lung transplantation.Keywords: lung transplant, bronchiolitis obliterans syndrome, rejection
url http://www.dovepress.com/chronic-lung-allograft-dysfunction-following-lung-transplantation-chal-peer-reviewed-article-TRRM
work_keys_str_mv AT bemissbc chroniclungallograftdysfunctionfollowinglungtransplantationchallengesandsolutions
AT wittca chroniclungallograftdysfunctionfollowinglungtransplantationchallengesandsolutions
_version_ 1716178033783603200